Oxford Index Search Results

You are looking at 21-40 of 56 items for:

15-16-17 x Gastroenterology x clear all

Refine by type

Refine by product

 

P327 Symptom relevance attributed by inflammatory bowel disease patients has a differential impact on their quality of life

F Casellas, C Herrera de Guise, V Robles, E Navarro, M Guirola and N Borruel.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The role of inflammatory bowel disease (IBD) symptoms and their importance in the management of...

Go to Oxford Journals »  home page

P482 Transanal minimally invasive proctectomy (TaMIP) in patients with inflammatory bowel diseases (IBD) within the TaTME international database

G Pellino, K Sahnan, M Penna, S Adegbola, P Chandrasinghe, A Spinelli, R Hompes and J Warusavitarne.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The necessity of proctectomy in IBD often represents refractory disease, with severe...

Go to Oxford Journals »  home page

P462 Mucosal healing and deep remission rates with azathioprine in inflammatory bowel disease?

Ü Dağlı, D Özer Etik, N Demir, S Öcal, H Selçuk, F Hilmioğlu and S Boyacıoğlu.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The goal in the treatment of inflammatory bowel disease (IBD) is to provide mucosal healing and...

Go to Oxford Journals »  home page

P693 Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?

A Walsh, A Kormilitzin, C Hinds, V Sexton, J Wilson, O Brain, S Keshav, H Uhlig, J Geddes, G Goodwin, M Peters, G Collins and S Travis.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The Simple Clinical Colitis Index (SCCAI) is a clinical index specific to ulcerative colitis...

Go to Oxford Journals »  home page

P678 Risk of malnutrition in patients with inflammatory bowel diseases: Results from an Italian multi-centre observational cross-sectional study

C Viganò, A Losco, I Bergna, G Meucci and A Amato.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Prevalence of malnutrition in patients with inflammatory bowel diseases (IBD) has not yet been...

Go to Oxford Journals »  home page

DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registry

D Turner, S Koletzko, H Winter, R Baldassano, M Dubinsky, W Faubion, J Hyams, S Kugathasan, J Rosh, J Escher, A Griffiths, J Kierkus, R Russell, G Heap, D Arikan, V Kuehnl, J Petersson, A Robinson and F Ruemmele.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The 3-year safety and efficacy data of adalimumab (ADA) in children and adolescents with...

Go to Oxford Journals »  home page

P718 Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life survey

P Marchi, S Timeus, L Mackenzie-Smith, P Le Calvé and R Young.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

In ulcerative colitis (UC) low adherence to treatment is a predictor for disease flares....

Go to Oxford Journals »  home page

P815 How to measure environmental exposures (the exposome) in inflammatory bowel disease?

K van der Sloot, B Alizadeh and G Dijkstra.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The aetiology of inflammatory bowel disease (IBD) is complexly shaped with a major contribution...

Go to Oxford Journals »  home page

P515 Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: A pilot randomised controlled trial

D Turner, H Vlamakis, D Marcus, M Yassour, J Bishai, B Yerushalmi, A Griffiths, M Aloi, L Albenberg, K -L Kolho, G Abutbul, A Assa, R Xavier and A Levine.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

A previous case series suggested a benefit of antibiotic-cocktail in steroid-refractory...

Go to Oxford Journals »  home page

P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

C Eriksson, S Rundquist, V Lykiardopoulos, P Karlén, O Grip, C Söderman, S Almer, E Hertervig, J Gunnarsson, C Malmgren, J Delin, H Strid, M Sjöberg, D Öberg, D Bergemalm, R Udumyan, H Hjortswang and J Halfvarson.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Clinical trials may not readily reflect clinical practice. We aimed to assess the clinical...

Go to Oxford Journals »  home page

P631 Treatment of established post-operative recurrence of Crohn’s disease with anti-TNF agents: Preliminary data of a multicentre, nationwide study

F Cañete, M Mañosa, M Barreiro-de Acosta, E Iglesias, R Ríos, R C González-Sueyro, A Villoria, M Navarro-Llavat, I Rodriguez-Lago, C Taxonera, P Navarro, P López, L Ramos, M Van Domselaar, A Algaba, M J Casanova, C Muñoz-Villafranca, R Pajares, M Sampedro, M Rivero, P G Delgado-Guillena, A Hernández, C Aràjol, A F Pordomingo, M Piqueras, E Sáinz-Arnau, O Benítez-Leiva, P Ramírez-de la Piscina, E Cabré and E Domènech.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Thiopurines are the treatment of choice for the prevention of postoperative recurrence (POR) in...

Go to Oxford Journals »  home page

P465 Do infliximab trough levels differ between adult and paediatric patients with Crohn’s disease in clinical remission?

A Cavazza, N Mavroeidi, A Steel, L Greathead, W Kelleher and M Wahed.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Infliximab (IFX) rapidly induces remission and provides long-term maintenance of remission in...

Go to Oxford Journals »  home page

P386 Methotrexate use in combination with anti-TNFα agents in IBD: A tertiary centre experience

W Waddingham, A Nwaogu, E Michael, L Whitley, H Parker, R Kettle, I Parisi, E Seward, S McCartney, S Bloom, R Vega, F Rahman and S Mehta.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Combination therapy (CT) with infliximab (IFX) and azathioprine (Aza) appears more clinically...

Go to Oxford Journals »  home page

P457 Biological interventions for induction and maintenance of mucosal healing in ulcerative colitis: A Cochrane systematic review

A Ricciuto, A Al-Darmaki, M J Stewart, N S Ding, H H Shim, M Storr, R Panaccione and C Seow.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The number of biologics for ulcerative colitis (UC) is rapidly expanding and mucosal healing...

Go to Oxford Journals »  home page

P162 The value of CMV DNA PCR in stool samples from IBD patients

J Li, Y Huang and X Yang.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

The aim of our study was to evaluate the value of the detection of CMV DNA in stool samples as...

Go to Oxford Journals »  home page

P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results

B Bressler, A -J Greenup, M Bassel, D Stein, M Soni, G Radulescu, C Neish, J M Khalid and D Demuth.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Vedolizumab (VDZ) is a gut-selective anti-α4β7 integrin indicated for the treatment (Tx) of...

Go to Oxford Journals »  home page

N029 Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD)

T Tyrrell, L Whitley, J Adio, K Greveson, A Hall, H Yarrow, L Medcalf and H Parker.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

A combination of both topical (suppositories or enemas) with oral mesalazines are first-line...

Go to Oxford Journals »  home page

P468 Microscopic colitis: systematic analysis of 200 adult patients with a mean follow-up of 4 years

H Maye, E Safroneeva, S Godat and A Schoepfer.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Microscopic colitis (MC) encompasses two main entities, lymphocytic colitis (LC) and...

Go to Oxford Journals »  home page

P575 Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease

L Guidi, D Pugliese, T Panici Tonucci, B Tolusso, C Felice, C Di Mario, A Papa, E Gremese, A Gasbarrini, G L Rapaccini and A Armuzzi.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

Vedolizumab is an α4β7 integrin antagonist for the treatment of inflammatory bowel disease...

Go to Oxford Journals »  home page

P572 Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomes

E Dreesen, D Laharie, G Lambrecht, P Bossuyt, A Buisson, J Filippi, P Van Hootegem, G D'Haens, S Vermeire and A Gils.

in Journal of Crohn's and Colitis

January 2018; p ublished online January 2018 .

Journal Article. Subjects: Medicine and Health; Clinical Medicine; Gastroenterology; Gastro-intestinal and Colorectal Surgery; Health, Illness, and Medicine. 0 words.

Abstract

Background

In TAILORIX, “proactive” dose escalation based on infliximab (IFX) serum concentrations (TDM...

Go to Oxford Journals »  home page